Maider Medical Industry Equipment Co. Ltd. (SHA:688310)
China · Delayed Price · Currency is CNY 14.20
+0.10 (0.71%)
Sep 14, 2026, 3:00 PM CST
SHA:688310 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,297 | 2,508 | 1,790 | 3,530 | 2,102 | 3,852 | |
Market Cap Growth | -30.00% | 40.12% | -49.28% | 67.94% | -45.44% | 56.84% |
Enterprise Value | 2,102 | 2,240 | 1,589 | 3,257 | 1,818 | 3,523 |
Last Close Price | 14.20 | 15.10 | 10.64 | 20.57 | 12.16 | 22.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 56.29 | 38.63 | - | 35.36 | 31.36 | 59.75 |
Forward PE | - | 9.97 | 9.97 | 22.52 | 14.65 | 36.14 |
PS Ratio | 4.92 | 5.61 | 6.51 | 7.35 | 5.48 | 12.21 |
PB Ratio | 2.98 | 2.87 | 2.12 | 3.75 | 2.53 | 5.05 |
P/TBV Ratio | 3.14 | 3.07 | 2.35 | 4.23 | 2.73 | 5.33 |
P/FCF Ratio | - | 25.79 | - | 91.20 | - | - |
P/OCF Ratio | 112.68 | 16.59 | 31.65 | 31.83 | 21.59 | 45.38 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 4.51 | 5.01 | 5.78 | 6.78 | 4.74 | 11.17 |
EV/EBITDA Ratio | 41.67 | 26.20 | 713.37 | 24.28 | 22.33 | 55.50 |
EV/EBIT Ratio | 205.43 | 47.73 | - | 30.81 | 27.38 | 61.80 |
EV/FCF Ratio | - | 23.04 | - | 84.17 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.08 | 0.07 | 0.04 | 0.00 | 0.00 | 0.00 |
Debt / EBITDA Ratio | 1.28 | 0.73 | 10.51 | 0.01 | 0.02 | 0.04 |
Debt / FCF Ratio | - | 0.65 | - | 0.05 | - | - |
Net Debt / Equity Ratio | -0.25 | -0.37 | -0.28 | -0.36 | -0.35 | -0.46 |
Net Debt / EBITDA Ratio | -3.84 | -3.78 | -106.82 | -2.56 | -3.54 | -5.55 |
Net Debt / FCF Ratio | 5.40 | -3.32 | 8.08 | -8.87 | 7.53 | 12.68 |
Asset Turnover | 0.42 | 0.40 | 0.25 | 0.44 | 0.40 | 0.37 |
Inventory Turnover | 1.51 | 1.65 | 1.11 | 1.81 | 1.77 | 1.58 |
Quick Ratio | 1.52 | 2.19 | 2.72 | 2.97 | 2.62 | 4.84 |
Current Ratio | 2.52 | 2.98 | 3.78 | 3.78 | 3.29 | 5.95 |
Return on Equity (ROE) | 1.56% | 5.18% | -3.36% | 12.39% | 9.68% | 8.54% |
Return on Assets (ROA) | 0.57% | 2.62% | -1.67% | 6.04% | 4.33% | 4.20% |
Return on Invested Capital (ROIC) | 0.86% | 5.92% | -4.90% | 15.98% | 12.33% | 14.36% |
Return on Capital Employed (ROCE) | 1.20% | 5.00% | -3.30% | 11.00% | 7.90% | 7.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.85% | 2.59% | -1.12% | 2.83% | 3.19% | 1.67% |
FCF Yield | -1.53% | 3.88% | -1.65% | 1.10% | -1.82% | -0.72% |
Dividend Yield | 1.67% | 1.65% | - | 1.74% | 2.01% | 0.88% |
Payout Ratio | 134.42% | 1.95% | - | 40.34% | 47.40% | 64.83% |
Buyback Yield / Dilution | -5.55% | 2.50% | -1.75% | 0.60% | -0.32% | -0.63% |
Total Shareholder Return | -3.88% | 4.15% | -1.75% | 2.33% | 1.69% | 0.26% |